Ranking the efficiency of gas hydrate anti agglomerants through molecular dynamic simulations

Using both computational and experimental methods, the capacity of four different surfactant molecules to inhibit the agglomeration of sII hydrate particles was assessed. The computational simulations were carried out using both steered and non-steered Molecular Dynamics (MD), simulating the coalescence process of a hydrate slab and a water droplet, both covered with surfactant molecules. The experimental work was based on rocking cell measurements, determining the minimum effective dose necessary to inhibit agglomeration. Overall, good agreement was obtained between the performance predicted by the simulations and the experimental measurements. Moreover, the simulations allowed to gain additional insights that are not directly accessible via experiments, such as an analysis of the mass density profiles, the diffusion coefficients, or the orientations of the long tails

Dynamics and Timescales of Higher Order Correlations in Hard Sphere Systems in Supercooled Colloidal Systems

The dynamics and time scales of higher-order correlations are studied in supercooled colloidal systems. A combination of X-ray photon correlation spectroscopy (XPCS) and X-ray cross-correlation analysis (XCCA) shows the typical slowing of the dynamics of a hard sphere system when approaching the glass transition. The time scales of higher-order correlations are probed using a novel time correlation function g$_C$, tracking the time evolution of cross-correlation function C. With an increasing volume fraction, the ratio of relaxation times of g$_C$ to the standard individual particle relaxation time obtained by XPCS increases from ∼0.4 to ∼0.9. While a value of ∼0.5 is expected for free diffusion, the increasing values suggest that the local orders within the sample are becoming more long-lived for larger volume fractions. Furthermore, the dynamics of local order is more heterogeneous than the individual particle dynamics. These results indicate that not only the presence but also the lifetime of locally favored structures increases close to the glass transition

Bioaccumulation of therapeutic drugs by human gut bacteria

Bacteria in the gut can modulate the availability and efficacy of therapeutic drugs. However, the systematic mapping ofthe interactions between drugs and bacteria has only started recently' and the main underlying mechanism proposed is the chemical transformation of drugs by microorganisms (biotransformation). Here we investigated the depletion of 15 structurally diverse drugs by 25 representative strains of gut bacteria. This revealed 70 bacteria-drug interactions, 29 of which had not to our knowledge been reported before. Over half of the new interactions can be ascribed to bioaccumulation; that is, bacteria storing the drug intracellularly without chemically modifying it, and in most cases without the growth ofthe bacteria being affected. As a case in point, we studied the molecular basis of bioaccumulation of the widely used antidepressant duloxetine by using click chemistry, thermal proteome profiling and metabolomics. We find that duloxetine bindsto several metabolic enzymes and changes the metabolite secretion of the respective bacteria. When tested in a defined microbial community of accumulators and non-accumulators, duloxetine markedly altered the composition of the community through metabolic cross-feeding. We further validated our findings in an animal model, showing that bioaccumulating bacteria attenuate the behavioural response of Caenorhabditis elegansto duloxetine. Together, our results show that bioaccumulation by gut bacteria may be a common mechanism that alters drug availability and bacterial metabolism, with implications for microbiota composition, pharmacokinetics, side effects and drug responses, probably in an individual manner